• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴基斯坦人群中PPARγ基因Pro12Ala(rs1801282)变异与类风湿关节炎的关联

Association of Pro12Ala (rs1801282) variant of PPAR gamma with rheumatoid arthritis in a Pakistani population.

作者信息

Jalil Syed Fazal, Ahmed Iltaf, Gauhar Zeeshan, Ahmed Mushtaq, Malik Javaid M, John Peter, Bhatti Attya

机构信息

Atta-Ur-Rahman School of Applied Biosciences (ASAB), National University of Science and Technology (NUST), Islamabad, 44000, Pakistan,

出版信息

Rheumatol Int. 2014 May;34(5):699-703. doi: 10.1007/s00296-013-2768-2. Epub 2013 Apr 30.

DOI:10.1007/s00296-013-2768-2
PMID:23633103
Abstract

Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) belongs to a receptor superfamily of ligand-activated transcription factors, encoded by PPARG gene. Role of PPARγ has been well established in variety of metabolic disorders and in regulation of inflammation. In the present study, we aimed to investigate the association of PPARG (Pro12Ala; rs1801282) in clinically definite Pakistani Rheumatoid Arthritis (RA) patients and matching controls. The genotypes of the Pro12Ala variant in the PPARG were determined in a sample of 300 Pakistanis, including 150 RA cases and 150 controls. The genotyping was performed using Amplification Refractory Mutation System-Polymerase Chain Reaction (ARMS-PCR) method, and the data was analyzed through Graphpad Prism 5 V software. Allele-specific primer set (two forward: PPARG-F1, PPARG-F2 and a common reverse primer: PPARG-R) was used for amplification, and the product was resolved on 2 % agarose gel. The CC (ProPro) genotype has higher frequency in controls than RA cases [75 (50.0 %) vs. 51 (34.0 %)], whereas the CG (ProAla) genotype has relatively same frequencies in both cases and controls [72 (48.0 %) vs. 70 (46.6 %)]. However, significantly higher frequency of GG (AlaAla) genotype was observed in cases [27 (18.0 %) vs. 5 (3.3 %); χ2 18.54; p < 0.0001]. Furthermore, the minor allele G has significantly higher allele frequency in cases having same trend and direction of association (OR 1.991(1.412-2.808); p < 0.0001). These observations suggest that Pro12Ala (rs1801282), a coding variant in the PPARG gene, is associated with Rheumatoid Arthritis in Pakistanis.

摘要

过氧化物酶体增殖物激活受体γ(PPAR-γ)属于配体激活转录因子的受体超家族,由PPARG基因编码。PPARγ在多种代谢紊乱和炎症调节中的作用已得到充分证实。在本研究中,我们旨在调查PPARG(Pro12Ala;rs1801282)在临床确诊的巴基斯坦类风湿性关节炎(RA)患者及匹配对照中的相关性。在300名巴基斯坦人的样本中确定了PPARG中Pro12Ala变体的基因型,其中包括150例RA患者和150名对照。使用扩增阻滞突变系统-聚合酶链反应(ARMS-PCR)方法进行基因分型,并通过Graphpad Prism 5 V软件分析数据。等位基因特异性引物组(两条正向引物:PPARG-F1、PPARG-F2和一条通用反向引物:PPARG-R)用于扩增,产物在2%琼脂糖凝胶上进行分离。CC(ProPro)基因型在对照中的频率高于RA患者[75(50.0%)对51(34.0%)],而CG(ProAla)基因型在患者和对照中的频率相对相同[72(48.0%)对70(46.6%)]。然而,在患者中观察到GG(AlaAla)基因型的频率显著更高[27(18.0%)对5(3.3%);χ2 18.54;p<0.0001]。此外,小等位基因G在具有相同关联趋势和方向的患者中的等位基因频率显著更高(OR 1.991(1.412 - 2.808);p<0.0001)。这些观察结果表明,PPARG基因中的编码变体Pro12Ala(rs1801282)与巴基斯坦人的类风湿性关节炎相关。

相似文献

1
Association of Pro12Ala (rs1801282) variant of PPAR gamma with rheumatoid arthritis in a Pakistani population.巴基斯坦人群中PPARγ基因Pro12Ala(rs1801282)变异与类风湿关节炎的关联
Rheumatol Int. 2014 May;34(5):699-703. doi: 10.1007/s00296-013-2768-2. Epub 2013 Apr 30.
2
The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma (PPARG) gene in relation to obesity and metabolic phenotypes in a Taiwanese population.台湾人群中过氧化物酶体增殖物激活受体γ(PPARG)基因Pro12Ala多态性与肥胖及代谢表型的关系
Endocrine. 2015 Apr;48(3):786-93. doi: 10.1007/s12020-014-0407-7. Epub 2014 Sep 3.
3
[Association of the Pro12Ala polymorphism in peroxisome proliferators activated receptor-gamma gene with rheumatoid arthritis in Sichuan Province of China].[中国四川省过氧化物酶体增殖物激活受体γ基因Pro12Ala多态性与类风湿关节炎的相关性]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009 Feb;26(1):87-90. doi: 10.3760/cma.j.issn.1003-9406.2009.01.020.
4
Prevalence of the rs1801282 single nucleotide polymorphism of the PPARG gene in patients with metabolic syndrome.代谢综合征患者中PPARG基因rs1801282单核苷酸多态性的患病率。
Arch Endocrinol Metab. 2015 Aug;59(4):297-302. doi: 10.1590/2359-3997000000086.
5
Lack of tumor necrosis factor alpha gene polymorphism -857c/t (rs1799724) association in Pakistani rheumatoid arthritis patients.巴基斯坦类风湿关节炎患者中缺乏肿瘤坏死因子α基因多态性-857c/t(rs1799724)关联。
Int J Rheum Dis. 2016 Nov;19(11):1119-1125. doi: 10.1111/1756-185X.12857. Epub 2016 Apr 28.
6
Association study of rs1801282 PPARG gene polymorphism and immune cells and cytokine levels in a Spanish pregnant women cohort and their offspring.西班牙孕妇队列及其后代中 rs1801282 PPARG 基因多态性与免疫细胞和细胞因子水平的关联研究。
J Biomed Sci. 2020 Nov 30;27(1):101. doi: 10.1186/s12929-020-00694-3.
7
Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.结节病患者中过氧化物酶体增殖物激活受体γ/Pro12Ala多态性与过氧化物酶体增殖物激活受体γ辅激活因子-1α/Gly482Ser多态性
Sarcoidosis Vasc Diffuse Lung Dis. 2008 Sep;25(1):29-35.
8
Peroxisome proliferator-activated receptor-gamma2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are not associated with hypertension in diabetes mellitus type 2.过氧化物酶体增殖物激活受体γ2 Pro12Ala和内皮型一氧化氮合酶-4a/b基因多态性与2型糖尿病患者的高血压无关。
J Hypertens. 2005 Feb;23(2):301-8. doi: 10.1097/00004872-200502000-00012.
9
Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control study.匈牙利队列病例对照研究分析 PPARγ 和 EPHX1 多态性与 COPD 易感性的关系。
BMC Med Genet. 2010 Nov 2;11:152. doi: 10.1186/1471-2350-11-152.
10
Biochemical investigation of rs1801282 variations in PPAR-γ gene and its correlation with risk factors of diabetes mellitus in coronary artery disease.对 PPAR-γ 基因 rs1801282 变异的生化研究及其与冠心病糖尿病危险因素的相关性。
Clin Exp Pharmacol Physiol. 2020 Sep;47(9):1517-1529. doi: 10.1111/1440-1681.13339. Epub 2020 May 31.

引用本文的文献

1
Updating the Pharmacological Effects of α-Mangostin Compound and Unraveling Its Mechanism of Action: A Computational Study Review.更新 α-倒捻子素化合物的药理作用及其作用机制的研究进展:计算研究综述。
Drug Des Devel Ther. 2024 Oct 24;18:4723-4748. doi: 10.2147/DDDT.S478388. eCollection 2024.
2
Association of IL-17F rs2397084 (E126G), rs11465553 (V155I) and rs763780 (H161R) variants with rheumatoid arthritis and their effects on the stability of protein.IL-17F rs2397084(E126G)、rs11465553(V155I)和 rs763780(H161R) 变异与类风湿关节炎的关联及其对蛋白质稳定性的影响。
PLoS One. 2023 Sep 26;18(9):e0285874. doi: 10.1371/journal.pone.0285874. eCollection 2023.
3

本文引用的文献

1
The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma-2 gene (PPARγ2) is associated with increased risk of coronary artery disease: a meta-analysis.过氧化物酶体增殖物激活受体 γ-2 基因(PPARγ2)Pro12Ala 多态性与冠心病风险增加相关:一项荟萃分析。
PLoS One. 2012;7(12):e53105. doi: 10.1371/journal.pone.0053105. Epub 2012 Dec 31.
2
[Association of the Pro12Ala polymorphism in peroxisome proliferators activated receptor-gamma gene with rheumatoid arthritis in Sichuan Province of China].[中国四川省过氧化物酶体增殖物激活受体γ基因Pro12Ala多态性与类风湿关节炎的相关性]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009 Feb;26(1):87-90. doi: 10.3760/cma.j.issn.1003-9406.2009.01.020.
3
A glimpse of the connection between PPARγ and macrophage.
PPARγ与巨噬细胞之间联系的一瞥。
Front Pharmacol. 2023 Aug 28;14:1254317. doi: 10.3389/fphar.2023.1254317. eCollection 2023.
4
and polymorphisms in connective tissue diseases and lipid disorders.以及结缔组织疾病和脂代谢紊乱相关的基因多态性。
Clin Interv Aging. 2018 Mar 22;13:463-472. doi: 10.2147/CIA.S157186. eCollection 2018.
5
Quantitative PPARγ expression affects the balance between tolerance and immunity.PPARγ 的定量表达影响耐受性与免疫之间的平衡。
Sci Rep. 2016 May 25;6:26646. doi: 10.1038/srep26646.
6
Development of ARMS-PCR assay for genotyping of Pro12Ala SNP of PPARG gene: a cost effective way for case-control studies of type 2 diabetes in developing countries.用于PPARG基因Pro12Ala单核苷酸多态性基因分型的ARMS-PCR检测方法的开发:发展中国家2型糖尿病病例对照研究的一种经济有效的方法。
Mol Biol Rep. 2014 Sep;41(9):5585-91. doi: 10.1007/s11033-014-3213-7. Epub 2014 Jul 26.
7
Meta-analysis of associations between the peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism and susceptibility to nonalcoholic fatty liver disease, rheumatoid arthritis, and psoriatic arthritis.过氧化物酶体增殖物激活受体γ Pro12Ala多态性与非酒精性脂肪性肝病、类风湿关节炎和银屑病关节炎易感性之间关联的荟萃分析。
Genet Test Mol Biomarkers. 2014 May;18(5):341-8. doi: 10.1089/gtmb.2013.0503. Epub 2014 Apr 3.
Association of the PPARgamma gene polymorphism Pro12Ala with delayed onset of multiple sclerosis.
过氧化物酶体增殖物激活受体γ基因多态性Pro12Ala与多发性硬化症发病延迟的关联。
Neurosci Lett. 2009 Jan 2;449(1):81-3. doi: 10.1016/j.neulet.2008.10.066. Epub 2008 Nov 1.
4
Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial.罗格列酮用于活动性溃疡性结肠炎:一项随机安慰剂对照试验。
Gastroenterology. 2008 Mar;134(3):688-95. doi: 10.1053/j.gastro.2007.12.012. Epub 2007 Dec 7.
5
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.国际药理学联合会。LX I. 过氧化物酶体增殖物激活受体。
Pharmacol Rev. 2006 Dec;58(4):726-41. doi: 10.1124/pr.58.4.5.
6
Catalase and PPARgamma2 genotype and risk of rheumatoid arthritis in Koreans.过氧化氢酶和PPARγ2基因型与韩国人患类风湿关节炎的风险
Rheumatol Int. 2006 Mar;26(5):388-92. doi: 10.1007/s00296-005-0013-3. Epub 2005 Jun 30.
7
Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2 protects against atherosclerosis.过氧化物酶体增殖物激活受体γ2的丙氨酸12丙氨酸基因型可预防动脉粥样硬化。
J Clin Endocrinol Metab. 2004 Sep;89(9):4238-42. doi: 10.1210/jc.2003-032120.
8
Genetic variation in PPARG encoding peroxisome proliferator-activated receptor gamma associated with carotid atherosclerosis.编码过氧化物酶体增殖物激活受体γ的PPARG基因变异与颈动脉粥样硬化相关。
Stroke. 2004 Sep;35(9):2036-40. doi: 10.1161/01.STR.0000138784.68159.a5. Epub 2004 Jul 29.
9
Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes.PPARG基因的Pro12Ala和C1431T变异及其单倍型与2型糖尿病易感性的关联。
Diabetologia. 2004 Mar;47(3):555-558. doi: 10.1007/s00125-003-1323-1. Epub 2004 Jan 17.
10
Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone.使用过氧化物酶体增殖物激活受体γ配体罗格列酮治疗48周后,非酒精性脂肪性肝炎病情改善。
Hepatology. 2003 Oct;38(4):1008-17. doi: 10.1053/jhep.2003.50420.